Litcius/Paper detail

Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)

Sarah Alsukait, Christine Learned, David Rosmarin

2023Journal of Drugs in Dermatology16 citationsDOIOpen Access PDF

Abstract

Citation: Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098Oral Tofacitinib, Discoid Lupus Erythematosus (DLE)

Topics & Concepts

MedicineOpen labelTofacitinibDiscoid lupus erythematosusDermatologyLupus erythematosusInternal medicineClinical trialImmunologyRheumatoid arthritisAntibodySystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchCytokine Signaling Pathways and Interactions
Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) | Litcius